These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 24990370)

  • 1. Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer.
    Richter C; Dy RL; McKenzie RE; Watson BN; Taylor C; Chang JT; McNeil MB; Staals RH; Fineran PC
    Nucleic Acids Res; 2014 Jul; 42(13):8516-26. PubMed ID: 24990370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system.
    Staals RH; Jackson SA; Biswas A; Brouns SJ; Brown CM; Fineran PC
    Nat Commun; 2016 Oct; 7():12853. PubMed ID: 27694798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoidance of Trinucleotide Corresponding to Consensus Protospacer Adjacent Motif Controls the Efficiency of Prespacer Selection during Primed Adaptation.
    Musharova O; Vyhovskyi D; Medvedeva S; Guzina J; Zhitnyuk Y; Djordjevic M; Severinov K; Savitskaya E
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation.
    Maikova A; Boudry P; Shiriaeva A; Vasileva A; Boutserin A; Medvedeva S; Semenova E; Severinov K; Soutourina O
    mBio; 2021 Aug; 12(4):e0213621. PubMed ID: 34425703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
    Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
    J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
    Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
    Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
    He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
    Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands.
    Vercoe RB; Chang JT; Dy RL; Taylor C; Gristwood T; Clulow JS; Richter C; Przybilski R; Pitman AR; Fineran PC
    PLoS Genet; 2013 Apr; 9(4):e1003454. PubMed ID: 23637624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-spacer integration reporter plasmids reveal distinct genuine acquisition specificities among CRISPR-Cas I-E variants of Escherichia coli.
    Díez-Villaseñor C; Guzmán NM; Almendros C; García-Martínez J; Mojica FJ
    RNA Biol; 2013 May; 10(5):792-802. PubMed ID: 23445770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Spacer and Protospacer Sequence Requirements in the Vibrio cholerae Type I-E CRISPR/Cas System.
    Bourgeois J; Lazinski DW; Camilli A
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of CRISPR adaptation in vitro and its detection by PCR.
    Fagerlund RD; Ferguson TJ; Maxwell HWR; Opel-Reading HK; Krause KL; Fineran PC
    Methods Enzymol; 2019; 616():411-433. PubMed ID: 30691653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.
    Nicholson TJ; Jackson SA; Croft BI; Staals RHJ; Fineran PC; Brown CM
    RNA Biol; 2019 Apr; 16(4):566-576. PubMed ID: 30157725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of the Haloarcula hispanica CRISPR-Cas system to a purified virus strictly requires a priming process.
    Li M; Wang R; Zhao D; Xiang H
    Nucleic Acids Res; 2014 Feb; 42(4):2483-92. PubMed ID: 24265226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types.
    Wu WY; Jackson SA; Almendros C; Haagsma AC; Yilmaz S; Gort G; van der Oost J; Brouns SJJ; Staals RHJ
    CRISPR J; 2022 Aug; 5(4):536-547. PubMed ID: 35833800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming in a permissive type I-C CRISPR-Cas system reveals distinct dynamics of spacer acquisition and loss.
    Rao C; Chin D; Ensminger AW
    RNA; 2017 Oct; 23(10):1525-1538. PubMed ID: 28724535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput analysis of type I-E CRISPR/Cas spacer acquisition in E. coli.
    Savitskaya E; Semenova E; Dedkov V; Metlitskaya A; Severinov K
    RNA Biol; 2013 May; 10(5):716-25. PubMed ID: 23619643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers.
    Zhang Z; Pan S; Liu T; Li Y; Peng N
    J Bacteriol; 2019 Jun; 201(12):. PubMed ID: 30936372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spacer acquisition from RNA mediated by a natural reverse transcriptase-Cas1 fusion protein associated with a type III-D CRISPR-Cas system in Vibrio vulnificus.
    González-Delgado A; Mestre MR; Martínez-Abarca F; Toro N
    Nucleic Acids Res; 2019 Nov; 47(19):10202-10211. PubMed ID: 31504832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.